The Cooper Companies, Inc. (NASDAQ:COO) Position Increased by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% in the second quarter, Holdings Channel.com reports. The institutional investor owned 38,814 shares of the medical device company’s stock after purchasing an additional 1,026 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Cooper Companies were worth $3,393,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Franklin Resources Inc. grew its position in shares of Cooper Companies by 1.2% during the fourth quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after acquiring an additional 41 shares during the last quarter. LRI Investments LLC increased its stake in shares of Cooper Companies by 4.5% in the second quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after purchasing an additional 112 shares during the period. Commonwealth Equity Services LLC raised its holdings in shares of Cooper Companies by 0.8% during the second quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after buying an additional 118 shares during the last quarter. First Horizon Advisors Inc. boosted its position in shares of Cooper Companies by 4.8% during the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after buying an additional 125 shares during the period. Finally, American International Group Inc. grew its holdings in Cooper Companies by 1.0% in the 4th quarter. American International Group Inc. now owns 13,229 shares of the medical device company’s stock worth $5,006,000 after buying an additional 137 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insider Activity at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, COO Daniel G. Mcbride sold 114,992 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The disclosure for this sale can be found here. Insiders sold 141,381 shares of company stock worth $14,927,361 in the last quarter. 2.00% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on COO. Wells Fargo & Company lifted their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Morgan Stanley lifted their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $115.00.

Cooper Companies Trading Up 0.6 %

Shares of NASDAQ:COO opened at $110.53 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The stock has a market capitalization of $22.01 billion, a price-to-earnings ratio of 65.02, a PEG ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $112.38. The company has a 50 day moving average price of $96.59 and a 200 day moving average price of $95.27.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s revenue was up 7.8% compared to the same quarter last year. During the same period last year, the company posted $0.84 EPS. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.